Sign In
Buy XTL
$238.31
-9.31 (-3.76%)
At Close: Jun 03, 2026
XTL Announces Receipt of Staff Delist Determination from Nasdaq
04:10pm, Friday, 22'nd May 2026
RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Let
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now?
07:21am, Friday, 22'nd May 2026
Designed to provide broad exposure to the Communication Services ETFs category of the market, the State Street SPDR S&P Telecom ETF (XTL) is a smart beta exchange traded fund launched on 01/26/2011.
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum
Telecom ETF Hit a 52-Week High
08:00am, Friday, 17'th Apr 2026
Telecom ETF XTL hits a 52-week high, soaring about 149% from lows. Backed by 5G, AI-driven demand & defensive strength -- momentum suggests more upside ahead.
SPDR S&P Telecom ETF (NYSEARCA:XTL) Hits New 52-Week High – Here’s Why
02:31am, Wednesday, 15'th Apr 2026
SPDR S&P Telecom ETF (NYSEARCA:XTL - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $211.84 and last traded at $209.12, with a volume of 2
XTL: Amazon For Globalstar Is Just The Latest Catalyst
02:24pm, Tuesday, 14'th Apr 2026
Amazon.com, Inc.'s $11.6 billion acquisition of Globalstar highlights surging demand for space-focused telecom, boosting XTL, where GSAT is the largest holding. I maintain a buy rating on the State St
XTL Biopharmaceuticals Announces ADS Ratio Change
04:10pm, Friday, 20'th Mar 2026
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it plans to change the ratio of it
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now?
07:21am, Thursday, 19'th Mar 2026
The State Street SPDR S&P Telecom ETF (XTL) was launched on 01/26/2011, and is a smart beta exchange traded fund designed to offer broad exposure to the Communication Services ETFs category of the mar
Telecom ETF (XTL) Touches New 52-Week High
08:01am, Thursday, 05'th Mar 2026
For investors seeking momentum, the State Street SPDR S&P Telecom ETF XTL is probably on the radar now. The fund just hit a 52-week high and is up 126.8% from its 52-week low price of $85.16 per shar
SPDR S&P Telecom ETF (NYSEARCA:XTL) Short Interest Update
01:36am, Monday, 02'nd Mar 2026
SPDR S&P Telecom ETF (NYSEARCA:XTL - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling 26,577
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
04:30pm, Friday, 27'th Feb 2026
RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Le
SPDR S&P Telecom ETF (NYSEARCA:XTL) Short Interest Up 110.6% in January
02:54am, Sunday, 01'st Feb 2026
SPDR S&P Telecom ETF (NYSEARCA:XTL - Get Free Report) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 34,617 shares, a gro
XTL Update on Recent Developments
04:05pm, Thursday, 29'th Jan 2026
RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced that it is working diligently to close the acq
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors
03:19am, Tuesday, 27'th Jan 2026
Arkadios Wealth Advisors bought a new position in SPDR S&P Telecom ETF (NYSEARCA:XTL) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 4,
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
04:10pm, Friday, 23'rd Jan 2026
RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification lett
